New Evidence Links Calcium Channel Blockers to Increased Risk of Glaucoma
Use of calcium channel blockers (CCBs), particularly cardioselective agents,…
Browsing Tag
Glaucoma
Glaucoma Treatment Market Report (2023 to 2031) – Alcon, Merck & Co., Inc.,…
Newark, New Castle, USA, June 13, 2023 (GLOBE NEWSWIRE) -- The market analysis of the global glaucoma treatment market was conducted by Growth Plus Reports in 2022 and is valued at US$…
Clinical Challenges: Treatment Options for Dry Eye Disease
With a plethora of nonpharmacologic and pharmacologic treatments for dry eye disease (DED), clinicians must choose…
Lifestyle Factors and Glaucoma: Lots of Common Sense, Not So Much Evidence
SAN DIEGO -- Limited data support a role for lifestyle factors in the prevention or management of glaucoma, according to a…
Sight Sciences Announces 12-month Results from the First Minimally Invasive Glaucoma…
<!-- Name:DistributionId Value:8833302 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Sight Sciences’ Glaucoma and Dry Eye Technologies to be Featured in Multiple…
<!-- Name:DistributionId Value:8829308 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:True -->…
Researchers discover therapeutic target to aid in glaucoma treatment
Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.
Glaucoma is a neurodegenerative disease…
Eye Drops can Prevent Nearsightedness
Once established, myopia is irreversible and can contribute to additional vision issues such as macular degeneration, retinal detachment, glaucoma, and cataracts. Since the 1970s, the…
Low brain pressure could be a risk factor for developing glaucoma
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts…